Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different …
TA Pearson, MA Denke, PE McBride, WP Battisti… - Mayo Clinic …, 2006 - Elsevier
OBJECTIVE To examine whether the improvements in lipid profiles and low-density
lipoprotein cholesterol (LDL-C) goal attainment found in the Ezetimibe Add-On to Statin for …
lipoprotein cholesterol (LDL-C) goal attainment found in the Ezetimibe Add-On to Statin for …
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the …
TA Pearson, MA Denke, PE McBride, WP Battisti… - Mayo Clinic …, 2005 - Elsevier
OBJECTIVE To determine the extent of reduction in low-density lipoprotein cholesterol (LDL-
C) level and improvement in National Cholesterol Education Program Adult Treatment Panel …
C) level and improvement in National Cholesterol Education Program Adult Treatment Panel …
Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome
M Denke, T Pearson, P McBride… - Diabetes and …, 2006 - journals.sagepub.com
This analysis of the Ezetimibe Add-on to Statin for Effectiveness (EASE) trial examined the
effectiveness and safety of ezetimibe 10 mg added to ongoing statin therapy in patients with …
effectiveness and safety of ezetimibe 10 mg added to ongoing statin therapy in patients with …
Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis
BM Ambegaonkar, D Tipping, AB Polis, JE Tomassini… - Atherosclerosis, 2014 - Elsevier
Objective: Evaluate the lipid-altering effects of ezetimibe added to ongoing statin therapy,
statin titration, switching from statin monotherapy to a more potent statin or to …
statin titration, switching from statin monotherapy to a more potent statin or to …
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 …
D Morrone, WS Weintraub, PP Toth, ME Hanson… - Atherosclerosis, 2012 - Elsevier
OBJECTIVE: Patients with dyslipoproteinemia constitute the largest risk group for
development of atherosclerosis and cardiovascular disease (CVD). Despite extensive statin …
development of atherosclerosis and cardiovascular disease (CVD). Despite extensive statin …
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult …
T Feldman, M Koren, W Insull Jr, J McKenney… - The American journal of …, 2004 - Elsevier
This study assessed whether the co-administration of ezetimibe and simvastatin would be
more effective than simvastatin monotherapy in allowing high-risk patients to achieve a low …
more effective than simvastatin monotherapy in allowing high-risk patients to achieve a low …
Begin with the Real-world Patients of Non-goal-achieved Hypercholesterolemia in Taiwan through the Ezetimibe/Simvastatin Tablet–the BRAVO study
JC Huang, TY Lee, MJ Liou, CM Lin, D Pei… - … medical research and …, 2011 - Taylor & Francis
Objective: To assess the efficacy, safety, and tolerability of a combination of 10 mg ezetimibe
and 20 mg simvastatin in Taiwanese patients with hypercholesterolemia. Research design …
and 20 mg simvastatin in Taiwanese patients with hypercholesterolemia. Research design …
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome
L Simons, M Tonkon, L Masana… - … medical research and …, 2004 - Taylor & Francis
Objective: To conduct a post-hoc assessment of the lipid-modifying effects of adding the
cholesterol absorption inhibitor, ezetimibe, to on-going statin therapy in patients with …
cholesterol absorption inhibitor, ezetimibe, to on-going statin therapy in patients with …
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
C Gagné, HE Bays, SR Weiss, P Mata, K Quinto… - The American journal of …, 2002 - Elsevier
Ezetimibe is a lipid-lowering drug that inhibits the intestinal absorption of dietary and biliary
cholesterol by blocking passage across the intestinal wall. The efficacy and safety of adding …
cholesterol by blocking passage across the intestinal wall. The efficacy and safety of adding …
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial …
PP Toth, CM Ballantyne, MH Davidson… - Journal of clinical …, 2012 - Elsevier
BACKGROUND: Recent trends suggest a decreased use of ezetimibe/simvastatin
combination and coadministered ezetimibe plus statin therapies. OBJECTIVE: This analysis …
combination and coadministered ezetimibe plus statin therapies. OBJECTIVE: This analysis …